- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Mount Sinai Today
By the People, for the People
HeartBeam Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development
Partnership aims to accelerate training and validation of AI models for personalized cardiac insights and remote patient monitoring.
Published on Mar. 10, 2026
Got story updates? Submit your updates here. ›
HeartBeam, a medical technology company, announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New York to accelerate the joint development and validation of next-generation AI-ECG algorithms. The partnership will combine HeartBeam's patented ECG platform with Mount Sinai's clinically annotated 12-lead ECG datasets and artificial intelligence expertise.
Why it matters
This collaboration aims to advance AI-driven cardiac monitoring by leveraging longitudinal, high-fidelity synthesized 12-lead ECG data collected from patients in home settings alongside Mount Sinai's clinical data resources. The goal is to accelerate the training and validation of AI models designed to support personalized cardiac insights, expand potential clinical indications, and enable broader applications in preventive cardiology, chronic disease management, and remote patient monitoring.
The details
The partnership will combine HeartBeam's patented ECG platform, which captures the heart's electrical activity from three non-coplanar dimensions, with Mount Sinai's clinically annotated 12-lead ECG datasets and artificial intelligence expertise. By leveraging this data and expertise, the collaboration aims to accelerate the training and validation of AI models designed to support personalized cardiac insights, expand potential clinical indications, and enable broader applications in preventive cardiology, chronic disease management, and remote patient monitoring.
- HeartBeam received FDA clearance for its 3D ECG technology for arrhythmia assessment in December 2024.
- HeartBeam received FDA clearance for its 12-lead ECG synthesis software in December 2025.
The players
HeartBeam, Inc.
A medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The company has developed a patented ECG platform that captures the heart's electrical activity from three non-coplanar dimensions.
Icahn School of Medicine at Mount Sinai
A leading medical school in New York that will provide clinically annotated 12-lead ECG datasets and artificial intelligence expertise to support the collaboration with HeartBeam.
The takeaway
This collaboration between HeartBeam and Mount Sinai represents a significant step forward in the development of advanced AI-driven cardiac monitoring technologies. By combining HeartBeam's innovative ECG platform with Mount Sinai's clinical expertise and data resources, the partnership aims to accelerate the creation of personalized cardiac insights and enable more effective remote patient monitoring solutions, ultimately improving cardiac health management.
